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Abstract
1a,25-Dihydroxyvitamin D3 (1a,25(OH)2D3) had earlier been regarded as the only active hormone. The newly identified
actions of 25-hydroxyvitamin D3 (25(OH)D3) and 24R,25-dihydroxyvitamin D3 (24R,25(OH)2D3) broadened the vitamin D3
endocrine system, however, the current data are fragmented and a systematic understanding is lacking. Here we performed
the first systematic study of global gene expression to clarify their similarities and differences. Three metabolites at
physiologically comparable levels were utilized to treat human and mouse fibroblasts prior to DNA microarray analyses.
Human primary prostate stromal P29SN cells (hP29SN), which convert 25(OH)D3 into 1a,25(OH)2D3 by 1a-hydroxylase
(encoded by the gene CYP27B1), displayed regulation of 164, 171, and 175 genes by treatment with 1a,25(OH)2D3,
25(OH)D3, and 24R,25(OH)2D3, respectively. Mouse primary Cyp27b1 knockout fibroblasts (mCyp27b1
2/2), which lack 1a-
hydroxylation, displayed regulation of 619, 469, and 66 genes using the same respective treatments. The number of shared
genes regulated by two metabolites is much lower in hP29SN than in mCyp27b12/2. By using DAVID Functional Annotation
Bioinformatics Microarray Analysis tools and Ingenuity Pathways Analysis, we identified the agonistic regulation of calcium
homeostasis and bone remodeling between 1a,25(OH)2D3 and 25(OH)D3 and unique non-classical actions of each
metabolite in physiological and pathological processes, including cell cycle, keratinocyte differentiation, amyotrophic lateral
sclerosis signaling, gene transcription, immunomodulation, epigenetics, cell differentiation, and membrane protein
expression. In conclusion, there are three distinct vitamin D3 hormones with clearly different biological activities. This study
presents a new conceptual insight into the vitamin D3 endocrine system, which may guide the strategic use of vitamin D3 in
disease prevention and treatment.
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Introduction
Vitamin D3 produced in the skin undergoes two sequential
hydroxylation steps, first 25-hydroxylation generating 25-hydro-
xyvitamin D3 (25(OH)D3) and then 1a-hydroxylation generating
1a,25-dihydroxyvitamin D3 (1a,25(OH)2D3). Both of them are
further metabolized by 24-hydroxylase. Among many endoge-
nous vitamin D3 metabolites, 25(OH)D3 and 24R,25-dihydrox-
yvitamin D3 (24R,25(OH)2D3) are the first and second most
abundant circulating metabolites of vitamin D3. 1a,25(OH)2D3
is believed to be the most active vitamin D3 metabolite. Their
classic actions in calcium homeostasis and non-classical actions
in cell proliferation and differentiation have been the focus of
vitamin D3 research.
During the past two decades, there have been some important
discoveries of vitamin D3 metabolism and endocrine system. Cells
can uptake 25(OH)D3 by megalin-mediated endocytosis [1,2].
25(OH)D3 possesses an inherent hormonal activity regulating cell
proliferation and gene expression, which was first evidenced in
human prostate cells [3] and later in other types of human and
mouse cells by in vitro as well as in vivo studies [4–13]. 25(OH)D3
acts synergistically with 1a,25(OH)2D3 [4]. 24R,25(OH)2D3 seems
to regulate specifically chondrocytes [14] and osteogenesis [15].
25(OH)D3 1a-hydroxylase, encoded by the gene CYP27B1 and
responsible for the conversion of 25(OH)D3 to 1a,25(OH)2D3, is
expressed in the kidney and in many extra-renal tissues [16–18],
thus the intracellularly synthesized 1a,25(OH)2D3 was suggested to
act as an intracrine factor [9]. Epidemiological studies provide
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accumulating evidence showing that vitamin D3 insufficiency is
associated with infection [19], cancers [20], fractures [21],
diabetes [22], and neuropsychiatric disease [23], and 25(OH)D3
concentration gradient is related to the seasonal variation of
cancer survival [24]. The optimal dose and serum concentration of
vitamin D3 is under debate. Some epidemiological studies also
suggest that both low and high 25(OH)D3 levels are harmful
[9,25,26]. Based on these findings, it seems that the vitamin D3
system is more complex than earlier thought.
To identify target genes, microarray gene expression studies
have been performed in various cellular systems after treatment
with 1a,25(OH)2D3, reviewed by C. Kriebitzsch, et al [27]. Gene
expression in response to 25(OH)D3 or 24R,25(OH)2D3 has not
yet been studied by DNA microarray. Here we compared the
effects of 1a,25(OH)2D3, 25(OH)D3, and 24R,25(OH)2D3 on gene
expression patterns to clarify similarities and differences in signal
transduction. To exclude the effect of the intracellular product of
1a,25(OH)2D3, we also performed microarray study in mouse
primary Cyp27b1 knockout fibroblasts (mCyp27b12/2). To our
knowledge, microarray gene expression studies have not been
made in mCyp27b12/2 cells. Our data show that there are three
vitamin D3 (cholecalcipherol) hormonal systems, which display
partially independent gene transcriptional effects.
Materials and Methods
Ethics Statement
All the animal experiments were approved by the Ethical
Committee of the University of Tampere. Animal care and
experimental procedures were conducted in accordance with the
European legislation and the guidelines of the Federation of
European Laboratory Animal Associations.
Mice
Cyp27b1 knockout (Cyp27b12/2) mice were bred at the
University of Tampere from the line initially generated at the
Shriners Hospital, Montreal, Canada [28]. Feeding and genotyp-
ing Cyp27b12/2 mice were described previously [4].
Cell Culture, Vitamin D3 Treatment, and RNA Isolation
The isolation and characterization of human primary prostate
stromal P29SN cells were described previously [3]. The vast
majority of the primary stromal culture was shown to be
fibroblasts in phenotype. Over 99% of the cells were positive for
fibroblast markers vimentin and fibronectin. Less than 5% of the
cells were positive for smooth muscle actin and less than 2% were
positive for desmin [3]. The cells were maintained in phenol red-
free DMEM/F12 medium (Sigma-Aldrich, Steinheim, Germany),
supplemented with 10% fetal bovine serum (FBS), 3 mM L-
glutamine, 5 mg/ml insulin, and antibiotics (penicillin 100 units/
ml, streptomycin 100 mg/ml) (Gibco-BRL, Life Technology,
Paisley, Scotland) at 37uC in a humid atmosphere with 5%
CO2. 24 hours prior to treatments, growth media containing 10%
FBS-DCC (10% FBS treated with dextran coated charcoal) were
added to semi-confluent hP29SN cells. Next day the cells were
treated with 0.1% ethanol, 10 nM 1a,25(OH)2D3, 500 nM
25(OH)D3, or 25 nM 24R,25(OH)2D3 (kindly provided by Leo
Pharmaceuticals, Ballerup, Denmark) for 24 hours. Ethanol
concentration was 0.1% in all treatment conditions. Experiments
were replicated four independent times for each treatment
condition.
The isolation and culture of mouse primary Cyp27b1 knockout
skin fibroblasts (mCyp27b12/2 fibroblasts) were described previ-
ously [4]. 48 hours prior to experiments, growth media were
supplemented with 10% FBS-DCC. Fibroblasts were treated with
0.1% ethanol, 10 nM 1a,25(OH)2D3, 500 nM 25(OH)D3, or
50 nM 24R,25(OH)2D3 for 24 hours. Ethanol concentration was
0.1% in all treatment conditions. Experiments were replicated four
independent times for each treatment condition.
Total cellular RNA was isolated from hP29SN stromal cells by
TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and from
mCyp27b12/2 fibroblasts by RNeasy Mini Kit (Qiagen GmbH,
Hilder, Germany) following the manufacturers’ protocols. The
RNA concentration and purity were verified using a GeneQuant
II (Pharmacia Biotech, Piscataway, NJ, USA). The A280/A260
ratio of all RNA samples utilized for experimentation was 1.9–2.1.
Randomly selected RNA samples were subjected to denaturing-gel
electrophoresis. The ratio of the intensity of 28S and 18S bands
was 1.5–2.0.
Quantitative Real-time RT-PCR (qRT-PCR)
CYP24A1 (encoding vitamin D3 24-hydroxylase) gene expression
was measured by using qRT-PCR to ensure that hP29SN stromal
cells were successfully stimulated by vitamin D3 metabolites.
Similarly, for the validation of microarray data, the expression
levels of eight differentially expressed genes in hP29SN stromal
cells and two genes in mCyp27b12/2 fibroblasts were analyzed.
The qRT-PCR analysis was performed as previously described
[3]. Briefly, total RNA was converted to cDNA by using High
Capacity Archive Kit and the 20 ng of cDNAs were used in real
time qPCR reactions by using SYBR Green PCR Master Mix kit
(Applied Biosystems, Foster City, CA, USA). Primers were
designed by using Primer Express v2.0 software (Applied
Figure 1. Gene expression profiles. Hierarchical clustering of the
differentially expressed genes in (A) hP29SN stromal cells and (B)
mCyp27b12/2 fibroblasts after vitamin D3 treatments. Colored-bands
represent the change of the corresponding gene expression, green
indicating down-regulation and red up-regulation. The key for
deciphering of the color is shown below the clustering image. Venn
diagrams of co-expressed and uniquely regulated genes by vitamin D3
metabolites in (C) hP29SN and (D) mCyp27b12/2 fibroblasts.
doi:10.1371/journal.pone.0075338.g001
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Biosystems, Foster City, CA, USA). The primer sequences are
listed in Table S1. The expression levels of target genes were
normalized against the housekeeping gene acidic ribosomal
phosphoprotein P0 (RPLP0) in hP29SN stromal cells and TATA
box binding protein (Tbp) in mCyp27b12/2 fibroblasts.
Affymetrix Microarray Analysis
cRNA preparation, hybridization, and the array wash proce-
dure were performed following the standard protocol from
Affymetrix. In brief, 7 mg of total RNA from each hP29SN
sample were used to synthesize double-stranded cDNA. The
cDNA was used as a template to generate biotinylated cRNA by
an in vitro transcription reaction. 20 mg of biotinylated cRNA was
fragmented and added to the GeneChipH Human Genome U133
Plus 2.0 Arrays (Affymetrix, Santa Clara, CA, USA). The
hybridization was carried out at 45uC for 20 hours with a rotation
at 60 rpm in an Affymetrix hybridization oven, and then the
arrays were washed and stained with a streptavidin-conjugated
fluorescent stain followed by antibody amplification on the
Affymetrix Fluidics Station 400. Scanned images were processed
using Affymetrix GeneChipH Operating Software Server 1.0
(GCOS Server) (Affymetrix, Santa Clara, CA, USA).
For mouse RNA samples, similar procedures were followed
except for the following: 250 ng of total RNA from each
mCyp27b12/2 sample was used as a starting material. Each
sample was hybridized to GeneChipH Mouse Genome 430 2.0
Arrays (Affymetrix, Santa Clara, CA, USA) at 45uC for 16 hours
according to 39 IVT Express Kit User Manual (Affymetrix, Santa
Clara, CA, USA). GeneChipH Fluidics Station 450 was used to
wash and stain the arrays. GeneChipH Scanner 3000 7G with
AutoLoader was used to scan the arrays.
Array Data Analysis
Data from array scans were normalized and analyzed by
GeneSpring GX 7.3.1 Expression Analysis software (Agilent
Technologies, Santa Clara, CA, USA). Before normalization,
expression values less than 0.01 were converted to 0.01 to enable
more efficient analysis of log-transformed data. To control chip-
wide variation in intensity values, each chip was normalized to the
50th percentile of all measurements (per-chip normalization). As
per gene normalization, treatment samples were normalized
against the median of control samples. Each measurement for
each gene in the treatment samples was divided by the median of
that gene’s measurements in the corresponding control samples. In
all three conditions, the present call was demanded only to
respective conditions. We used Pearson Correlation as similarity
measure and unsupervised average linkage hierarchical clustering
algorithm. The program was asked to merge similar branches with
separation ratio of one and minimum distance of 0.001 and to
calculate confidence levels (bootstrapping) with 100 datasets.
Figure 2. IPA diagrams of the top associated network generated for genes exclusively regulated by each metabolite in hP29SN
stromal cells. (A) Genes regulated by 1a,25(OH)2D3 in Cardiovascular System Development and Function, Tissue Development, Organismal
Development. (B) Genes regulated by 25(OH)D3 in Cell Death and Survival, Gene Expression, Tissue Morphology. (C) Genes regulated by 25(OH)D3 in
Cell Death and Survival, Cellular Growth and Proliferation, Cell Cycle. (D) Genes regulated by 24R,25(OH)2D3 in Cell Morphology, Cellular Function and
Maintenance, DNA Replication, Recombination, and Repair. Green indicates gene down-regulation and pink to red indicate gene up-regulation (the
more intensive the color, the higher the expression level). An asterisk (*) indicates that multiple identifiers in the microarray set map to a single gene.
doi:10.1371/journal.pone.0075338.g002
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The microarray data has been deposited to ArrayExpress with
the accession numbers of E-MTAB-1773 for human data and E-
MTAB-1774 for mouse data.
Functional Annotation, Network Generation and
Pathway Analyses
The DAVID Functional Annotation Bioinformatics Microarray
Analysis tools (http://david.abcc.ncifcrf.gov/) [29,30] were used
to study the biological meaning of regulated genes. Functional
properties of differentially expressed genes were further analyzed
in the context of Gene Ontology (GO) and molecular networks
using the Ingenuity Pathways Analysis (IPA; Ingenuity SystemsH;
http://www.ingenuity.com). The number of molecules in the
network was limited to default of 35, based on the number of
connections between the input genes and genes in the IPA
database. For each of the network, a score is calculated by the IPA
according to the fit of that network to the input genes. The score
(derived from a p-value) represents the likelihood of random
change. For example, a score of 2 indicates that there is a 1%
change that the input genes are together in a network due to
random change. Therefore, scores of 2 or higher have at least a
99% confidence of not being generated by random change alone.
The highest scoring networks were selected.
Results
Gene Expression Profiles Induced by Vitamin D3
Metabolites
We aimed at exploring the gene expression profiles of three
vitamin D3 metabolites using hP29SN stromal cells and
mCyp27b12/2 fibroblasts. Human P29SN stromal cells were
derived from a normal area of human prostatic carcinoma [3].
Mouse Cyp27b12/2 fibroblasts were derived from Cyp27b12/2
mice that do not express 25(OH)D3 1a-hydroxylase and therefore
cannot convert 25(OH)D3 into 1a,25(OH)2D3.
We verified the responsiveness and successful stimulation of cells
by vitamin D3 metabolites by measuring mRNA level of CYP24A1
in each sample by qRT-PCR before applying samples to
microarray assays (Figure S1). RNA samples of corresponding
metabolite treatments from randomly selected two sets of
experiments were pooled to generate final two sets of RNA for
microarray hybridizations.
The gene expression profiles in hP29SN stromal cells treated
with 10 nM 1a,25(OH)2D3, 500 nM 25(OH)D3, or 25 nM
24R,25(OH)2D3 were determined by GeneChipH Human Ge-
nome U133 Plus 2.0 Arrays that contained more than 54000
probe sets to analyze the expression level of more than 47000
transcripts and variants, including approximately 38500 well-
Figure 3. IPA diagrams of the top associated network generated for genes exclusively regulated by each metabolite in mCyp27b12/
2 fibroblasts. (A) Genes regulated by 1a,25(OH)2D3 in Tissue Morphology, Hematological System Development and Function, Humoral Immune
Response. (B) Genes regulated by 1a,25(OH)2D3 in Cardiovascular System Development and Function, Inflammatory Response, Cellular Movement. (C)
Genes regulated by 25(OH)D3 in Cellular Growth and Proliferation, Cellular Development, Hair and Skin Development and Function. (D) Genes
regulated by 24R,25(OH)2D3 in Cell Death and Survival, Endocrine System Development and Function, Lipid Metabolism. Green indicates gene down-
regulation and pink to red indicate gene up-regulation (the more intensive the color, the higher the expression level). An asterisk (*) indicates that
multiple identifiers in the microarray set map to a single gene.
doi:10.1371/journal.pone.0075338.g003
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characterized human genes. Ethanol-treated samples served as
negative control. Each vitamin D3 metabolite-treated sample was
compared with ethanol-treated samples. Only those genes that
exhibited at least twofold change in gene expression in parallel
experiments were reported to ensure the fidelity of the data. The
final result was the average of the two independent microarray
experiments. For 1a,25(OH)2D3 treatment, 164 genes met the
selection criteria while 171 and 175 genes were identified for
25(OH)D3 and 24R,25(OH)2D3 treatment, respectively (data not
shown). All the genes that displayed at least twofold expression
change in any of the treatments were clustered using hierarchical
clustering method by GeneSpring software (Figure 1A). To
understand the specific role of each vitamin D3 metabolite, we
grouped the regulated genes into commonly and uncommonly
regulated gene groups (Figure 1C). Of the genes met the selection
criteria, only 10 are common in all the three experimental
conditions. Interestingly, all these genes were up-regulated. The
number of genes significantly regulated in two conditions are 21
for 1a,25(OH)2D3 and 25OHD3, 8 for 1a,25(OH)2D3 and
24R,25(OH)2D3, and 20 for 25OHD3 and 24R,25(OH)2D3,
respectively (Figure 1C).
Mouse Cyp27b12/2 fibroblasts were treated either with 10 nM
1a,25(OH)2D3, 500 nM 25(OH)D3, or 50 nM 24R,25(OH)2D3,
and GeneChipH Mouse Genome 430 2.0 Arrays were used to
study the gene expression profile. Using a cut-off of twofold
expression change, we identified 619, 469, and 66 genes regulated
by 1a,25(OH)2D3, 25(OH)D3, and 24R,25(OH)2D3, respectively
(data not shown). Samples were grouped using hierarchical
clustering method based on the overall expression changes in the
samples (Figure 1B). The gene expression profile in 50 nM
Table 1. Top five associated network functions of genes exclusively regulated by single metabolite generated by IPA.
Human P29SN stromal cells
Metabolite Top associated network functions Score
1a,25(OH)2D3 Cardiovascular System Development and Function, Tissue Development, Organismal Development 16
Cellular Movement, Immune Cell Trafficking, Hematological System Development and Function 14
Cardiac Proliferation, Cardiovascular System Development and Function, Cell Cycle 2
Molecular Transport, Protein Synthesis, Protein Trafficking 2
Antimicrobial Response, Inflammatory Response, Antigen Presentation 2
25(OH)D3 Cell Death and Survival, Gene Expression, Tissue Morphology 25
Cell Death and Survival, Cellular Growth and Proliferation, Cell Cycle 23
Cell Cycle, Cancer, Cell Death and Survival 8
Cell Morphology, Cellular Growth and Proliferation, Cellular Assembly and Organization 2
Cell Cycle, DNA Replication, Recombination, and Repair, Cell Death and Survival 2
24R,25(OH)2D3 Cell Morphology, Cellular Function and Maintenance, DNA Replication, Recombination, and Repair 22
Gene Expression, Cellular Growth and Proliferation, Cell Cycle 20
Cellular Growth and Proliferation, Cellular Development, Cellular Movement 18
Cancer, Cell Death, Neurological Disease 2
Cell Death, Cellular Development, Digestive System Development and Function 2
Mouse Cyp27b12/2 fibroblasts
Metabolite Top associated network functions Score
1a,25(OH)2D3 Tissue Morphology, Hematological System Development and Function, Humoral Immune Response 28
Cardiovascular System Development and Function, Inflammatory Response, Cellular Movement 28
Cancer, Respiratory Disease, Carbohydrate Metabolism 22
Organismal Injury and Abnormalities, Cell Morphology, Lipid Metabolism 16
Cellular Growth and Proliferation, Cell Death and Survival, Cell Cycle 16
25(OH)D3 Cellular Growth and Proliferation, Cellular Development, Hair and Skin Development and Function 19
Cellular Function and Maintenance, Cell-mediated Immune Response, Cellular Development 17
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function 15
Gene Expression, Developmental Disorder, Cancer 15
Cell Death, Cancer, Cell Cycle 13
24R,25(OH)2D3 Cell Death and Survival, Endocrine System Development and Function, Lipid Metabolism 18
Connective Tissue Development and Function, Connective Tissue Disorders, Developmental Disorder 2
Developmental Disorder, Immunological Disease, Cell Cycle 2
Hereditary Disorder, Metabolic Disease, Cancer 2
Cancer, Cell Death and Survival, Cellular Compromise 2
doi:10.1371/journal.pone.0075338.t001
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24R,25(OH)2D3-treated cells displays much less changes com-
pared with ethanol control, suggesting lower bioactivity of
24R,25(OH)2D3. The Venn diagram shows six genes commonly
regulated by the three metabolites, 321 by 1a,25(OH)2D3 and
25OHD3, 9 by 1a,25(OH)2D3 and 24R,25(OH)2D3, and 4 by
25OHD3 and 24R,25(OH)2D3, respectively (Figure 1D).
Functional Annotation of Genes Regulated by Vitamin D3
Metabolites
The biological relevance of the specifically regulated genes by
each metabolite was further analyzed by the DAVID Functional
Annotation Bioinformatics Microarray Analysis tools (http://
david.abcc.ncifcrf.gov/) [29,30]. The most enriched GO catego-
ries with p-value ,0.05 are listed in Tables S2, S3, and S4. The
enriched GO categories show clear differences between the
profiles of the three metabolites, which suggests that each of them
has a unique biological role.
In hP29SN stromal cells, the highly enriched GO categories
related to 1a,25(OH)2D3-treatment include those involved in
nucleotide biosynthesis, ubiquitin conjugation, ion binding, and
macromolecule biosynthesis (Table S2). 25(OH)D3 plays numeral
roles in intracellular organelles, DNA-binding transcription
factors, protein-protein interaction, transcription coregulator
activity, RNA-binding motif, and organic acid biosynthesis (Table
S2). 24R,25(OH)2D3 appeared to be involved in the regulation of
zinc-finger motifs, methylation, transcription, epigenetics, protein
kinases, and membrane targeting (Table S2).
In mCyp27b12/2 fibroblasts, 1a,25(OH)2D3 is specifically
involved in cell differentiation, extracellular matrix, cell adhesion,
prostate gland development, cytokine and growth factor activity,
Table 2. Top five canonical pathways generated by IPA constructed from genes exclusively regulated by single metabolite.
Human P29SN stromal cells
Metabolite Top canonical pathways p-value Ratio
1a,25(OH)2D3 Amyotrophic Lateral Sclerosis Signaling 6.31E-03 3/100 (0.03)
TNFR1 Signaling 2/51 1.43E-02 2/51 (0.039)
Xenobiotic Metabolism Signaling 1.51E-02 4/262 (0.015)
PXR/RXR Activation 2/64 2.35E-02 2/64 (0.031)
RhoGDI Signaling 2.92E-02 3/188 (0.016)
25(OH)D3 Granzyme B Signaling 2.32E-03 2/16 (0.125)
Cell Cycle: G2/M DNA Damage Checkpoint Regulation 1.61E-02 2/48 (0.042)
Aryl Hydrocarbon Receptor Signaling 2.14E-02 3/141 (0.021)
Myc Mediated Apoptosis Signaling 2.83E-02 2/60 (0.033)
Cell Cycle: G1/S Checkpoint Regulation 2.92E-02 2/64 (0.031)
24R,25(OH)2D3 DNA Double-Strand Break Repair by Homologous Recombination 2.58E-03 2/16 (0.125)
ATM Signaling 3.73E-03 3/59 (0.051)
Complement System 1.32E-02 2/33 (0.061)
Role of BRCA1 in DNA Damage Response 4.27E-02 2/63 (0.032)
Melatonin Signaling 5.63E-02 2/71 (0.028)
Mouse Cyp27b12/2 fibroblasts
Metabolite Top canonical pathways p-value Ratio
1a,25(OH)2D3 Xenobiotic Metabolism Signaling 4.62E-03 9/263 (0.034)
Ephrin Receptor Signaling 7.42E-03 7/184 (0.037)
Hepatic Fibrosis/Hepatic Stellate Cell Activation 9.24E-03 6/138 (0.043)
Renal Cell Carcinoma Signaling 1.17E-02 4/69 (0.058)
Lipoate Biosynthesis and Incorporation II 2.66E-02 1/2 (0.5)
25(OH)D3 Aryl Hydrocarbon Receptor Signaling 2.59E-03 5/139 (0.036)
Metabolism of Xenobiotics by Cytochrome P450 3.15E-03 4/93 (0.043)
LPS/IL-1 Mediated Inhibition of RXR Function 1.32E-02 5/214 (0.023)
Xenobiotic Metabolism Signaling 2.96E-02 5/264 (0.019)
Arachidonic Acid Metabolism 4.34E-02 3/110 (-0.027)
24R,25(OH)2D3 Production of Nitric Oxide and Reactive Oxygen Species in Macrophages 4.67E-03 3/175 (0.017)
Ceramide Signaling 1.01E-02 2/78 (0.026)
Mineralocorticoid Biosynthesis 1.82E-02 1/10 (0.1)
Glucocorticoid Biosynthesis 2.02E-02 1/11 (0.091)
p70S6K Signaling 2.28E-02 2/120 (0.017)
doi:10.1371/journal.pone.0075338.t002
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cell motion, mesenchymal and epithelial cell proliferation, neuron
development, EGF, and gland development (Table S3). On the
other hand, 25(OH)D3 plays a different role, mainly in the
regulation of cell apoptosis, lipid transport, glycoprotein, extra-
cellular matrix components, blood vessel development, cell
proliferation, and response to wounding (Table S3). However,
24R,25(OH)2D3 appears to have very limited biological activity
based on the current detection method, only being involved in ion
binding (Table S3). We were also interested to know the common
biological roles of 25OHD3 and 1a,25(OH)2D3, and therefore
performed functional annotation analysis of 321 commonly
regulated genes. These gene products are involved in glycopro-
teins, extracellular matrix-related proteins and enzymes, EGF-like
calcium-binding, epithelium development, and cell morphogenesis
(Table S4).
Pathway Analyses and Network Generation of Genes
Exclusively Regulated by Vitamin D3 Metabolites
To reveal the possible biological interaction of specifically
regulated genes by each metabolite, we performed network
analyses using the IPA. The top five associated network functions
of genes exclusively regulated by single metabolite are summarized
in Table 1. 1a,25(OH)2D3-specific target genes are mostly
involved in ‘‘Cardiovascular System Development and Function,
Tissue Development, Organismal Development’’ (score 16,
Figure 2A) and ‘‘Cellular Movement, Immune Cell Trafficking,
Haematological System Development and Function’’ (score 14) in
hP29SN stromal cells and ‘‘Tissue Morphology, Hematological
System Development and Function, Humoral Immune Response’’
(score 28, Figure 3A) and ‘‘Cardiovascular System Development
and Function, Inflammatory Response, Cellular Movement’’
(score 28, Figure 3B) in mCyp27b12/2 fibroblasts. The most
populated biological networks for 25(OH)D3-specific target genes
are entitled ‘‘Cell Death and Survival, Gene Expression, Tissue
Morphology’’ (score 25, Figure 2B) and ‘‘Cell Death and Survival,
Cellular Growth and Proliferation, Cell Cycle’’ (score 23,
Figure 2C) in hP29SN stromal cells and ‘‘Cellular Growth and
Proliferation, Cellular Development, Hair and Skin Development
and Function’’ (score 19, Figure 3C) in mCyp27b12/2 fibroblasts.
24R,25(OH)2D3 specific target genes are mostly involved in ‘‘Cell
Morphology, Cellular Function and Maintenance, DNA Replica-
tion, Recombination, and Repair’’ (score 22, Figure 2D) and
‘‘Gene Expression, Cellular Growth and Proliferation, Cell Cycle’’
(score 20) in hP29SN stromal cells and ‘‘Cell Death and Survival,
Figure 4. IPA diagrams of the top associated network generated for all the regulated genes in hP29SN stromal cells. (A) Genes
regulated by 1a,25(OH)2D3 in Cancer, Cardiovascular System Development and Function, Cellular Movement. (B) Genes regulated by 1a,25(OH)2D3 in
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking. (C) Genes regulated by 25(OH)D3 in Cell Death and
Survival, Metabolic Disease, Endocrine System Disorders. (D) Genes regulated by 24R,25(OH)2D3 in Cellular Development, Reproductive System
Development and Function, Cell Morphology. Green indicates gene down-regulation and pink to red indicate gene up-regulation (the more intensive
the color, the higher the expression level).
doi:10.1371/journal.pone.0075338.g004
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Endocrine System Development and Function, Lipid Metabolism’’
(score 18, Figure 3D) in mCyp27b12/2 fibroblasts.
Furthermore, the top five canonical pathways for genes
exclusively regulated by a single metabolite are listed in Table 2.
The top canonical pathway in hP29SN stromal cells affected by
1a,25(OH)2D3, 25(OH)D3, and 24R,25(OH)2D3 is ‘‘Amyotrophic
Lateral Sclerosis Signaling’’ (p=0.006), ‘‘Granzyme B Signaling’’
(p=0.002), and ‘‘DNA Double-Strand Break Repair by Homol-
ogous Recombination’’ (p=0.003), respectively. The most affected
pathway in mCyp27b12/2 fibroblasts by 1a,25(OH)2D3,
25(OH)D3, and 24R,25(OH)2D3 is ‘‘Xenobiotic Metabolism
Signaling’’ (p=0.005), ‘‘Aryl Hydrocarbon Receptor Signaling’’
(p=0.003), and ‘‘Production of Nitric Oxide and Reactive Oxygen
Species in Macrophages’’ (p=0.005), respectively.
To have an overall view of the networks affected by each
metabolite, we constructed IPA network analyses using all the
regulated genes in hP29SN stromal cells (Figure 4) and
mCyp27b12/2 fibroblasts (Figure 5). The top five associated
network functions of all the genes regulated by single metabolite
are summarized in Table 3.
Validation by qRT-PCR
To validate the microarray data by an independent method, the
expression levels of eight genes in hP29SN stromal cells were
measured by qRT-PCR (Figure 6A–C). A good correlation
(R2 = 0.96) was detected between the two methods (Figure 6D).
Similarly, the expression of two genes in mCyp27b12/2 fibroblasts
was measured by qRT-PCR (Figure 6E–F).
Discussion
In order to analyze putative differential gene regulatory effects
of vitamin D3 metabolites, we performed cDNA microarray
analysis in hP29SN stromal cells. To rule out the effect of
intracellularly 25(OH)D3-derived 1a,25(OH)2D3, we also per-
formed cDNA microarray analysis in mCyp27b12/2 fibroblasts
that lack 25(OH)D3 1a-hydroxylase enzyme activity.
Figure 5. IPA diagrams of the top associated network generated for all the regulated genes in mCyp27b12/2 fibroblasts. (A) Genes
regulated by 1a,25(OH)2D3 in Cardiovascular System Development and Function, Organismal Development, Cancer. (B) Genes regulated by 25(OH)D3
in Humoral Immune Response, Inflammatory Response, Cellular Development. (C) Genes regulated by 25(OH)D3 in Cancer, Cellular Growth and
Proliferation, Connective Tissue Disorders. (D) Genes regulated by 24R,25(OH)2D3 in Hematological System Development and Function,
Hematopoiesis, Tissue Morphology. Green indicates gene down-regulation and pink to red indicate gene up-regulation (the more intensive the
color, the higher the expression level). An asterisk (*) indicates that multiple identifiers in the microarray set map to a single gene.
doi:10.1371/journal.pone.0075338.g005
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The optimal serum concentrations of 25(OH)D3 for good health
are still under discussion. The proposed normal range is broad and
variable in different populations perhaps due to an adaptation.
Several optimal concentrations have been proposed: 20–80 nM
[31], 50–250 nM [32], and 40–70 nM [9] have been suggested.
The international recommended optimal concentration of
25(OH)D3 is 50 nM or more. 40 nM or more is recommended
in Finland, 50 nM by the Institute of Medicine, 75–185 nM (30–
74 ng/ml) by MedlinePlus, and 100 nM by the Endocrine Society.
On the other hand, the normal serum concentration of
1a,25(OH)2D3 is clearly defined, being 0.03–0.14 nM [31]. The
concentration of 24R,25(OH)2D3 is approximately 1.44–8 nM
(0.6–2.9 ng/ml) [33]. The prefect experimental setup would be
using physiological concentrations of metabolites; however, it has
been shown that the metabolites at physiological concentrations
are not active in cell studies. To avoid bias in comparison and
ensure detectable responses, we have chosen 10-fold higher
concentrations of vitamin D metabolites over their normal serum
levels, which are approximately 50, 5, and 1 nM for 25(OH)D3,
24R,25(OH)2D3, and 1a,25(OH)2D3, respectively.
Here we identified 1a,25(OH)2D3 regulated genes involved in
immune functions, antibacterial response, and inflammation
(Figure 4 and Table 1) as well as DNA repair, cell growth and
death, and cell-matrix interaction (Tables S1, S3, and 3), which
have been previously described in other cell systems [34–36].
25OHD3 is an Active Hormone
Our study in mCyp27b12/2 fibroblasts suggests that gene
expression fingerprints of 1a,25(OH)2D3 and 25OHD3 are similar.
Among the genes regulated by 1a,25(OH)2D3 in mCyp27b1
2/2
Table 3. Top five associated network functions of all the genes regulated by single metabolite generated by IPA.
Human P29SN stromal cells
Metabolite Top associated network functions Score
1a,25(OH)2D3 Cancer, Cardiovascular System Development and Function, Cellular Movement 15
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking 15
Cell Death, Cell Morphology, DNA Replication, Recombination, and Repair 13
Hereditary Disorder, Neurological Disease, Ophthalmic Disease 2
Cardiac Proliferation, Cardiovascular System Development and Function, Cell Cycle 2
25(OH)D3 Cell Death and Survival, Metabolic Disease, Endocrine System Disorders 22
Cancer, Hematological Disease, Cellular Development 20
Cell Cycle, Cell Death and Survival, Cellular Compromise 18
Gene Expression, Cell Death and Survival, Amino Acid Metabolism 11
Gene Expression, RNA Post-Transcriptional Modification, Cell-To-Cell Signaling and Interaction 2
24R,25(OH)2D3 Cellular Development, Reproductive System Development and Function, Cell Morphology 25
Cell Cycle, Cell Death, Cellular Movement 19
Gene Expression, DNA Replication, Recombination, and Repair, Cardiovascular System Development and Function 17
Cell Cycle, Cellular Growth and Proliferation, DNA Replication, Recombination, and Repair 3
Hereditary Disorder, Neurological Disease, Ophthalmic Disease 2
Mouse Cyp27b12/2 fibroblasts
Metabolite Top associated network functions Score
1a,25(OH)2D3 Cardiovascular System Development and Function, Organismal Development, Cancer 40
Inflammatory Response, Hematological System Development and Function, Tissue Morphology 38
Inflammatory Response, Cellular Movement, Immune Cell Trafficking 26
Protein Synthesis, Cellular Development, Hematological System Development and Function 21
Dermatological Diseases and Conditions, Hereditary Disorder, Organismal Injury and Abnormalities 19
25(OH)D3 Humoral Immune Response, Inflammatory Response, Cellular Development 37
Cancer, Cellular Growth and Proliferation, Connective Tissue Disorders 37
Hematological System Development and Function, Humoral Immune Response, Tissue Morphology 25
Organismal Injury and Abnormalities, Inflammatory Response, Connective Tissue Disorders 18
Cellular Development, Connective Tissue Development and Function, Tissue Morphology 15
24R,25(OH)2D3 Hematological System Development and Function, Hematopoiesis, Tissue Morphology 26
Connective Tissue Development and Function, Connective Tissue Disorders, Developmental Disorder 2
Developmental Disorder, Immunological Disease, Cell Cycle 2
Cellular Development, Lipid Metabolism, Molecular Transport 2
Cellular Development, Hematological System Development and Function, Hematopoiesis 2
doi:10.1371/journal.pone.0075338.t003
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fibroblasts, 52% were also regulated by 25(OH)D3. On the other
hand, 68% of 25(OH)D3-regulated genes in mCyp27b1
2/2
fibroblasts were also regulated by 1a,25(OH)2D3. The majority
of overlapping genes are the most strongly regulated genes among
the top 15 in the lists. These data once further support previous
findings by us [3,4] and others [6–8,10,12] that 25(OH)D3 is
indeed an active hormone. Studies of 25(OH)D3 analog that is
hardly subjected to 1a-hydroxylation provide additional evidence
that 1a-hydroxylation of 25(OH)D3 is not required for its anti-
proliferative activity [12].
Human P29SN stromal cells express 25(OH)D3 1a-hydroxylase
that converts 25(OH)D3 into 1a,25(OH)2D3 and vitamin D3 24-
hydroxylase that converts 25(OH)D3 into 24R,25(OH)2D3 [3],
thus we could not rule out the effects of intracellular
1a,25(OH)2D3 and 24R,25(OH)2D3 products derived from
25OHD3. We observed that only a few genes commonly regulated
by 25(OH)D3 and 1a,25(OH)2D3 in hP29SN. Of the genes
regulated by one metabolite, only 12–13% were also regulated by
another metabolite. CYP24A1 was the most highly up-regulated
gene by 25(OH)D3 and 1a,25(OH)2D3 in both mouse and human
fibroblasts. It is worth mentioning that 24R,25(OH)2D3 did not
regulate CYP24A1 gene expression. An earlier microarray study
has also found the induction ratio of CYP24A1 gene expression by
1a,25(OH)2D3 was the highest among 3800 human genes
examined and 24R,25(OH)2D3 at a very high concentration
(1000 nM) did induce CYP24A1 gene expression [37]. The
expression of cholesterol 25-hydroxylase was increased more than
threefold by both 25(OH)D3 and 1a,25(OH)2D3 in hP29SN,
consistent with our previous study [38]. Both 25(OH)D3 and
1a,25(OH)2D3 increased the expression of insulin-like growth
factor 1 more than twofold in hP29SN.
These data indeed demonstrate unique roles for 25(OH)D3 and
1a,25(OH)2D3. Recent molecular dynamics simulations data [4]
indicate both 1a,25(OH)2D3 and 25(OH)D3 bind to the vitamin D
receptor (VDR) ligand-binding pocket at the same position,
resulting in identical agonistic conformation [4]. Microarray data
presented here further validate the biological significance of
25(OH)D3.
A Complementary Role of 25(OH)D3 and 1a,25(OH)2D3 in
Calcium and Skeletal Homeostasis
1a,25(OH)2D3 stimulates a number of genes involved in bone
formation [39,40] and osteoclast differentiation [41–43]. We
discovered several new 1a,25(OH)2D3-target genes involved in
bone physiology and pathology in hP29SN stromal cells and
mCyp27b12/2 fibroblasts. Na+/H+ exchanger domain containing
2 (NHEDC2, NHA2, SLC9B2), a member of Na+/H+ exchanger
Figure 6. Validation of gene expression by qRT-PCR. (A–C) Gene expression in hP29SN stromal cells. CH25H: cholesterol 25-hydroxylase; SSBP2:
single-stranded DNA binding protein 2; VHL: von Hippel-Lindau tumor suppressor; IGF1: insulin-like growth factor; EGFR: epidermal growth factor
receptor; LAMB1: laminin subunit b1; RAB7: RAB7A, member RAS oncogene family; MED1: mediator complex subunit 1. (D) Fold changes of gene
expression in hP29SN detected by either qRT-PCR or microarray are plotted and linear regression is shown by a solid line. (E–F) The expression of
endothelial lipase (Lipg) and tumor necrosis factor receptor superfamily, member 11b (Tnfrsf11b) in mCyp27b12/2 fibroblasts was measured by qRT-
PCR. Randomly selected two sets of experiments were pooled to generate final two sets of RNA samples for both microarray and qRT-PCR. Results are
expressed as means 6 SD.
doi:10.1371/journal.pone.0075338.g006
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family, was potently up-regulated by 1a,25(OH)2D3 (ca. tenfold) in
hP29SN stromal cells. Thus, it is tempting to link 1a,25(OH)2D3
action to bone resorption and remodeling based on a recently-
discovered role of NHEDC2 in osteoclast differentiation and fusion
[44,45]. Sex determining region Y-box 6 (SOX6), an osteoporosis
susceptibility gene shown by genome-wide association studies
[46,47], was up-regulated by more than twofold by 1a,25(OH)2D3
in hP29SN. Sox6 was shown to be essential for cartilage formation
in mice [48].
Contrary to human cells, we identified a different set of bone-
related genes as the targets of 1a,25(OH)2D3 in mCyp27b1
2/2
fibroblasts. Secreted frizzled related protein 1 (Sfrp1) was down-
regulated by 1a,25(OH)2D3. Sfrp1 was previously shown to inhibit
receptor activator of nuclear factor-kB ligand-dependent osteoclast
formation [49] and was strongly associated with bone mineral
density and bone mineral content [50]. Loss of Sfrp1 in mice
improves fracture repair [51], due to antagonism of the Wnt
pathway. Bone morphogenetic protein 1 (BMP1) was increased by
more than sevenfold by 1a,25(OH)2D3 in mCyp27b1
2/2 fibro-
blasts. BMP1 has been suggested to enhance bone repair [52].
25(OH)D3 shares some functions with 1a,25(OH)2D3 in
regulating calcium and skeletal homeostasis. Three calcium
homeostasis-related genes were regulated by 25(OH)D3 and
1a,25(OH)2D3 in both mouse and human fibroblasts. Voltage-
dependent calcium channel c-4 subunit (CACNG4) was up-
regulated in hP29SN stromal cells (more than twofold by
25(OH)D3 and more than threefold by 1a,25(OH)2D3). S100
calcium binding protein G (S100G, CABP9K, encoding calbindin
D9K) was dramatically up-regulated in mCyp27b12/2 fibroblasts
(88-fold by 25(OH)D3 and 85-fold by 1a,25(OH)2D3). Prolactin
receptor (PRLR) gene expression was up-regulated by more than
threefold by 25(OH)D3 and more than 12-fold 1a,25(OH)2D3 in
mCyp27b12/2 fibroblasts. PRLP was responsible for the growth
inhibitory effect of prolactin on prostate cells [53] and recently it
was found to participate in calcium homeostasis by multiple
mechanisms [54]. Two bone-related genes were regulated by both
25(OH)D3 and 1a,25(OH)2D3 in mCyp27b1
2/2 fibroblasts. The
expression of secreted frizzled related protein 2 (Sfrp2) was strongly
down-regulated by both 25(OH)D3 (sixfold) and 1a,25(OH)2D3
(sevenfold) in mCyp27b12/2 fibroblasts. Sfrp2 is an osteoporosis
susceptibility gene associated with bone mineral density [50]. In
addition, both 25(OH)D3 (more than fourfold) and 1a,25(OH)2D3
(more than fivefold) also inhibited the expression of tumor necrosis
factor receptor superfamily, member 11b (Tnfrsf11b, OPG,
osteoprotegerin) in mCyp27b12/2 fibroblasts. Osteoprotegerin
functions as a negative regulator of osteoclastogenesis and bone
resorption [55].
Collectively, studies in human prostate stromal cells and mouse
skin fibroblasts suggest that 25(OH)D3 and 1a,25(OH)2D3
complement each other in regulating calcium homeostasis and
bone remodeling. The role of 1a,25(OH)2D3 is broader than that
of 25(OH)D3. Our current findings support in vivo data that show
partial rescue of the phenotype of Cyp27b12/2 mice by vitamin D3
injection [10]. Although human prostate stromal cells and mouse
skin fibroblasts are neither the sites of calcium absorption nor the
responsible cells for bone formation, the current finding provides
new information with indications that require further studies in
intestine and bone cells. The action of 25(OH)D3 and
1a,25(OH)2D3 in calcium homeostasis in stromal cells and
fibroblasts may have two meanings. Firstly, the second messenger
Ca2+ is involved in many cellular processes, such as cell
proliferation, cell differentiation, cell-cell and cell-matrix interac-
tions, and cell movement. In fact, the role of 1a,25(OH)2D3 in
calcium homeostasis has been described in a microarray study of
LNCaP human prostate cancer cells [56]. Secondly, calcium
homeostasis in non-bone tissues may indicate soft tissue calcifica-
tion, which is also a major concern in vitamin D therapy. This is
evidenced by a microarray study of human artery smooth muscle
cells [57].
We did not find 24R,25(OH)2D3-target genes related to skeletal
homeostasis in hP29SN stromal cells and mCyp27b12/2 fibro-
blasts. This should be verified by in vitro bone cell studies. It might
also be possible that the previously discovered effect of
24R,25(OH)2D3 on the bone is non-genomic.
Non-classical Actions of Vitamin D3 Metabolites
To get an in-depth view of the actions of each metabolite, we
further analyzed the regulated genes not involved in bone and
calcium homeostasis. We discovered 1a,25(OH)2D3-mediated up-
regulation of several genes that negatively regulate cell cycle and
growth. Tyrosine kinase, non-receptor, 1 (TNK1), up-regulated by
more than sixfold in hP29SN, was earlier shown to facilitate tumor
necrosis factor a-induced apoptosis [58]. Cdk5 and Abl enzyme
substrate 1 (CABLES1), up-regulated by more than sixfold in
hP29SN, is involved in regulation of the cell cycle. Reduction of
CABLES1 expression was previously observed in colorectal cancers
[59]. Microcephalin 1 (MCPH1) was up-regulated by more than
fourfold in hP29SN. MCPH1 product acts as a DNA-damage
response protein and prevents premature entry into mitosis [60].
The vitamin D endocrine system plays an important role in skin
in both ligand-dependent and -independent manners [61].
Vitamin D and the VDR regulate a number of genes involved in
keratinocyte differentiation and hair follicle cycle. Here, we
identified three genes whose expression was specifically regulated
by 1a,25(OH)2D3 in mCyp27b1
2/2 fibroblasts. Keratin 17, a key
regulatory gene in hair development [62], was strongly induced by
1a,25(OH)2D3 (more than 13-fold). Cadherin 11, which is
expressed in mesenchymal aggregates during hair follicle devel-
opment [63], was up-regulated by 1a,25(OH)2D3 (threefold).
Transforming growth factor b2, shortening hair cycle by
stimulating certain caspases [64], was down-regulated by
1a,25(OH)2D3 (twofold). These findings provide additional
important mechanism by which 1a,25(OH)2D3 specifically regu-
lates hair development in a VDR-dependent manner.
The IPA analysis shows that amyotrophic lateral sclerosis (ALS)
signaling is the top canonical pathway of 1a,25(OH)2D3-mediated
genes in hP29SN stromal cells (Table 2). This finding supports the
recent hypothesis that vitamin D may delay ALS progression [65–
68].
A number of genes involved in gene transcription were
specifically modulated by 25(OH)D3 (Figures 2B and 2C). Nuclear
receptor coactivator 2 (NCOA2, SRC2) was induced by 8-fold, hairy
and enhancer of split 1 (HES1) by more than twofold, activating
transcription factor 6 (ATF6) by more than twofold, and nuclear
transcription factor Y, c (NFYC, CBF-C) by more than twofold in
hP29SN stromal cells. HES1, a Notch-target gene, is a transcrip-
tion factor involved in various events during development [69–72].
ATF6 mediates RUNX2-dependent osteocalcin expression in
osteoblasts [73] and apoptosis in myoblasts [74]. CBF-C represses
the transactivating activity of Smad2 and Smad3 [75]. Several
C2H2-like zinc-finger proteins that are involved in transcriptional
regulation, for example, YY2 transcription factor and zinc finger
proteins, were also induced by 25(OH)D3 in hP29SN.
Previous studies have linked vitamin D deficiency to various
inflammatory diseases and suggest a role for vitamin D in
immunity [76]. Our current study provides an alternative
mechanism of the immunomodulatory property of 25(OH)D3.
25(OH)D3 induced the expression of membrane-associated ring
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finger (C3HC4) 1 (MARCH1) more than sixfold in hP29SN
stromal cells. MARCH1 is an E3 ubiquitin ligase that down-
regulates major histocompatibility complex class I membrane
expression [77]. The immunosuppressive effect of interleukin-10 is
mediated by MARCH1 [78]. Furthermore, 25(OH)D3 increased
SAM domain and HD domain 1 (SAMHD1) expression more than
twofold in hP29SN. SAMHD1 plays a role in the innate immune
response and may regulate tumor necrosis factor a proinflamma-
tory responses [79]. Hepatitis A virus cellular receptor 2 (HAVCR2,
TIM3, T cell immunoglobulin-3) gene expression was increased
threefold by 25(OH)D3 in hP29SN. TIM3 fails to be up-regulated
in T cells in human autoimmune diseases, such as multiple
sclerosis [80]. TIM3 locus and specific gene polymorphisms are
associated with various immune-mediated diseases, such as
rheumatoid arthritis [81] and atopic disease [82]. These findings
are primary but important. Confirmation utilizing monocytes,
dendritic cells, and T cells for in vitro studies, together with
functional analyses, will bolster the importance of our conclusions.
24R,25(OH)2D3 is produced by CYP24A1 when there is enough
active vitamin D3 available. We identified two 24R,25(OH)2D3-
target genes involved in methylation and epigenetics in hP29SN
stromal cells. MLL5 (a trithorax homolog, myeloid/lymphoid or
mixed-lineage leukaemia 5) was up-regulated more than threefold
by 24R,25(OH)2D3. MLL5 is a known chromatin regulator in
H3K4 methylation [83]. Methyltransferase like 15 (METTL15,
METT5D1) was increased more than 15-fold by 24R,25(OH)2D3.
Human microarray data show that 24R,25(OH)2D3 modulate
cell differentiation and proliferation, in particular by strongly
influencing breast cancer 1, early onset (BRCA1) signaling pathway
(Figure 2D). BRCA1 expression was increased more than twofold
by 24R,25(OH)2D3. Induction of BRCA1 was previously found to
be partially responsible for the anti-proliferative effects of
1a,25(OH)2D3 [84]. Interestingly, cofactor of BRCA1 (COBRA1)
was reduced threefold by 24R,25(OH)2D3. BRCA1 and COBRA1
seem to function in coordinate gene regulatory pathways [85].
Tumor protein p53 binding protein 1 (TP53BP1) was up-regulated
by more than threefold by 24R,25(OH)2D3. TP53BP1 up-
regulates the promoter of BRCA1 [86]. Kinase suppressor of ras
2 (KSR2), a target of 1a,25(OH)2D3 [87], was increased by more
than fivefold by 24R,25(OH)2D3 in hP29SN. 24R,25(OH)2D3
regulates two hormone receptor coactivators. It decreased the
expression of mediator complex subunit 1 (MED1, TRAP220,
DRIP205) threefold. MED1 is a VDR coactivator [88]. It also
decreased thyroid hormone receptor associated protein 3 (twofold).
24R,25(OH)2D3 influences the expression of several membrane
proteins. Erythrocyte membrane protein band 4.1 like 5
(EPB4.1L5), which contributes to the correct positioning of tight
junction during the establishment of cell polarity [89], was
increased ninefold by 24R,25(OH)2D3 in hP29SNstromal cells.
Synaptotagmin XIV (SYT14) was up-regulated more than sixfold
in hP29SN. Regulating synaptic membrane exocytosis 2 (Rims2)
was up-regulated more than twofold in mCyp27b12/2 fibroblasts.
Both the gene products are involved in exocytosis.
Conclusions
The present study is the first systematic comparison of global
gene expression in hP29SN stromal cells and mCyp27b12/2
fibroblasts after treatment with 1a,25(OH)2D3, 25(OH)D3, and
24R,25(OH)2D3. It seems that there are three partially different
vitamin D3 (cholecalcipherol) hormonal systems. 25(OH)D3 and
1a,25(OH)2D3 complement each other in regulating calcium
homeostasis and bone remodeling. Each vitamin D3 metabolite
has unique non-classical actions in various physiological and
pathological processes. Our study presents a novel perspective for
the function of vitamin D3 within the endocrine system, and
furthers our understanding of the roles and relationships between
vitamin D3 metabolites. The limitation of our study is that some
regulated genes need to be clarified in relevant cells and tissues,
e.g. immune responsive genes and bone-related genes.
Supporting Information
Figure S1 Quantitative real-time RT-PCR (qRT-PCR)
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